ALS Life Sciences Limited, headquartered in Ireland (IE), is a prominent player in the global life sciences industry. Founded in 1976, the company has established itself as a leader in analytical testing and laboratory services, catering to a diverse range of sectors including pharmaceuticals, food and beverage, and environmental testing. With operational facilities across Europe, ALS Life Sciences offers a comprehensive suite of services, including microbiological testing, chemical analysis, and regulatory compliance support. Their commitment to quality and innovation sets them apart, ensuring clients receive accurate and timely results. Recognised for their expertise, ALS Life Sciences has achieved significant milestones, including numerous accreditations and partnerships that enhance their market position. Their dedication to scientific excellence and customer satisfaction continues to drive their success in the competitive life sciences landscape.
How does ALS Life Sciences Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Insurance Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
ALS Life Sciences Limited's score of 26 is lower than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
ALS Life Sciences Limited, headquartered in Ireland (IE), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that ALS Life Sciences Limited may not have established formal commitments to reduce carbon emissions or may not publicly disclose such information. In the context of the broader industry, many companies are increasingly adopting science-based targets and sustainability initiatives to address climate change. However, without specific commitments or emissions data, it is unclear how ALS Life Sciences Limited aligns with these industry standards.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
ALS Life Sciences Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
